1,2,4-Trimethylbenzene

1,2,4-トリメチルベンゼン

[CAS No. 95-63-6]

Pseudocumene

プソイドクメン

Molecular formula: C9H12 Molecular weight: 120.20

ABSTRACT

1,2,4-Trimethylbenzene was studied for oral toxicity in rats in a 28-day repeat dose toxicity test at doses of 0, 30, 100, 300 and 1000 mg/kg/day. With regard to repeat dose toxicity, in the males, salivation, increases in water consumption, relative kidney weights and hyaline droplet degeneration of urinary tubules in the kidney were seen at 300 mg/kg or more, and suppression of body weight gain and increases in urine volume, relative liver weights and absolute kidney weights were seen at 1000 mg/kg. In the females, salivation and increases in the absolute and relative liver weights were seen at 300 mg/kg or more, and suppression of body weight gain, increases in water consumption, urine volume and relative kidney weights were observed at 1000 mg/kg. The NOEL for repeat dose toxicity is considered to be 100 mg/kg/day for both sexes.

1,2,4-Trimethylbenzene was not mutagenic to Salmonella typhimurium TA100, TA98, TA1535, TA1537 and Escherichia coli WP2 uvrA, with or without an exogeneous metabolic activation system.

1,2,4-Trimethylbenzene induced neither structural chromosomal aberrations nor polyploidsy in CHL/IU cells up to a concentration (0.08-0.15 mg/ml) more than that causing 50% cell growth inhibition, in the absence or presence of an exogenous metabolic activation system.

SUMMARIZED DATA FROM THE STUDIES

1. Repeat Dose Toxicity 1)

Purity:98.75%
Test species/strain:Rat/Crj:CD (SD)
Test method:Guidelines for the 28-Day Repeat Dose Toxicity Test of Chemicals (Japan)
 Route:Oral (gavage)
 Doses:0 (vehicle), 30, 100, 300, 1000 mg/kg/day
 Number of animals/group:Males, 10 or 15 (0 and 1000 mg/kg)
Females, 10 or 15 (0 and 1000 mg/kg)
 Vehicle:Corn oil
 Administration period:Males, females; 28 days
 Terminal kill:Males, females; days 29 or 43 (0, 1000 mg/kg)
GLP:Yes

 Test results:

No deaths were found in any group. Salivation was seen in both sexes treated with 300 mg/kg or more. Suppression of body weight gain was noted in both sexes of the 1000 mg/kg group. Food consumption of both sexes of the treated groups was almost the same as that of the control group. Increased water consumption was seen in the males of the 300 mg/kg group and in both sexes of the 1000 mg/kg group. Urinalysis revealed increase in urine volume in both sexes of the 1000 mg/kg group but this disappeared before termination of the recovery period.

On hematological and blood chemical examinations, no changes were found for any parameter in either sex of the groups treated with 1,2,4-trimethylbenzene. At necropsy, no abnormalities were found in either sex of any group. For organ weights of the males, increases in the relative kidney weights were noted in the groups treated with 300 mg/kg or more, and increases of the relative liver weights and the absolute kidney weights were observed in the 1000 mg/kg group. For the females, increases in the absolute and relative liver weights were shown in the groups treated with 300 mg/kg or more, and increase in the relative kidney weight was noted for the 1000 mg/kg group. These changes had disappeared by the termination of the recovery period. On histopathological examination of the males, hyaline droplet degeneration of renal tubules had was found in the groups treated with 300 mg/kg or more. This finding had disappeared by the termination of the recovery period. No abnormalities attributable to the test compound administration were found in the females.

The NOEL of 1,2,4-trimethylbenzene by oral administration for 28-days is considered to be 100 mg/kg/day for both sexes.

2. Genetic Toxicity

2-1. Bacterial test 2)

Purity:98.75 %
Test species/strains:Salmonella typhimurium TA100, TA1535, TA98, TA1537, Escherichia coli WP2 uvrA
Test methods:Guidelines for Screening Mutagenicity Testing of Chemicals (Japan) and OECD (471 and 472)
 Procedures:Plate incorporation method
 Solvent:DMSO
 Positive controls:-S9 mix, 2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide (TA100, WP2, TA98), Sodium azide (TA1535)and 9-Aminoacridine (TA1537)
+S9 mix, 2-Aminoanthracene (five strains)
 Doses:-S9 mix, 0, 7.81, 15.6, 31.3, 62.5, 125 and 250 μg/plate (TA100, TA1535, TA98 and TA1537), 0, 15.6 - 500 μg/plate (WP2)
+S9 mix, 0, 7.81 - 250 μg/plate (TA1537), 0, 15.6 - 500 μg/plate (TA100, TA1535 and WP2), 0, 31.3 - 1000 μg/plate (TA98)
 S9:Rat liver, induced with phenobarbital and 5,6-benzoflavone
 Plates/test:3
 Number of replicates:2
GLP:Yes

 Test results:
This chemical did not induce gene mutations in the S. typhimurium and E. coli strains. Toxicity was observed at 125 μg/plate (TA100, TA1535, TA98 and TA1537), 250 μg/plate (WP2) without S9 mix, 125 μg/plate (TA1537), 250 μg/plate (TA100 and TA1535) and 500 μg/plate (WP2 and TA98) with S9 mix.

Genetic effects:
Salmonella typhimurium TA100, TA1535, TA98, TA1537
+?-
Without metabolic activation: [ ][ ][*]
With metabolic activation: [ ][ ][*]

Escherichia coli WP2 uvrA
+?-
Without metabolic activation: [ ][ ][*]
With metabolic activation: [ ][ ][*]

2-2. Non-bacterial in vitro test (chromosomal aberration test)

Purity:98.75%
Type of cell used:Chinese hamster lung (CHL/IU) cells
Test method:Guidelines for Screening Mutagenicity Testing of Chemicals (Japan)
 Solvent:Dimethylsulfoxide
 Positive controls:-S9 mix, Mitomycin C
+S9 mix, Cyclophosphamide
 Doses:-S9 mix (continuous treatment): 0, 0.020, 0.040,0.080 mg/ml
-S9 mix (short-term treatment): 0, 0.038, 0.075,0.15 mg/ml
+S9 mix (short-term treatment): 0, 0.025, 0.050.0.10 mg/ml
 S-9:Rat liver, induced with phenobarbital and 5,6-benzoflavone
 Plates/test:2
GLP:Yes

 Test results:
This chemical did not induce structural chromosomal aberrations or polyploidy under the conditions of this experiment.

Genotoxic effects:
 clastogenicitypolyploidy
+?-+?-
Without metabolic activation: [ ][ ][*] [ ][ ][*]
With metabolic activation: [ ][ ][*] [ ][ ][*]

1)The test was performed by Nihon Bioresearch Inc. Hashima Laboratory, 6-104 Majima, Fukuju-cho, Hashima, Gifu, 501-62 Japan Tel +81-58-392-6222 Fax +81-58-391-3171
2)The tests were performed by the Hatano Research Institute, Food and Drug Safety Center, 729-5 Ochiai, Hadano-shi, Kanagawa, 257, Japan. Tel +81-463-82-4751 Fax +81-463-82-9627